Cellular Therapies, Innovation
Sarah Conway
Beyond Oncology: The landmark cellular therapy ...

To mark Clinical Trials Day, we explore 5 landmark international trials redefining cellular therapy. From record-breaking oncology survival data to functional cures for severe autoimmunity and HIV, discover the breakthroughs transforming medicine from the lab to the bedside.

Beyond Oncology: The landmark cellular therapy trials redefining modern medicine
Quality & Safety, Regulatory Partnerships, Cellular Therapies, Innovation, Ethical Practices
Sarah Conway
Donor lymphocyte infusions: from reactive ...

Donor lymphocyte infusions (DLI) and clinical readiness. Discover Biovault’s pre-prepared DLI processing and storage approach for faster access and reduced risk.

Donor lymphocyte infusions: from reactive intervention to clinical readiness
Industry Events, Company News, Cellular Therapies
Sarah Conway
EBMT 2026: 5 Insights Shaping the Future of ...

5 key takeaways from EBMT 2026, from expanded cord blood and JACIE quality to regulation, infrastructure and the future of cell therapy.

EBMT 2026: 5 Insights Shaping the Future of Cell Therapy
Cellular Therapies, Innovation
Sarah Conway
The Evolution of Cell Therapy Part 3: Immune ...

Explore how PBSCs enabled CAR-T and immune effector cell therapies, and how Biovault supports safe processing, storage and delivery of advanced cellular medicines.

The Evolution of Cell Therapy Part 3: Immune Effector Cell Therapies
Cellular Therapies
Sarah Conway
The Evolution of Cell Therapy Part 2: ...

How peripheral blood stem cells became the preferred source for transplantation, and how Biovault supports PBSC collection pathways through compliant processing and storage.

The Evolution of Cell Therapy Part 2: Peripheral Blood Stem Cells

Company News